Liver-Directed Treatment Modalities for Primary and Secondary Hepatic Tumors

Surgical Clinics of North America

Volumn 89, Issue 1, 2009, Pages 97-113

  Yamane, Brett ^a   Weber, Sharon ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Ablation; Colorectal metastases; Embolization; Hepatocellular carcinoma; Liver directed therapies; Percutaneous ethanol injection; Radiotherapy

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMORBIDITY; CRYOABLATION; HUMAN; INTERMETHOD COMPARISON; LIVER FUNCTION; LIVER METASTASIS; LIVER TUMOR; MICROWAVE THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIMARY HEPATIC TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SECONDARY HEPATIC TUMOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CRYOSURGERY; ETHANOL; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MICROWAVES; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION;

EID: 58749083076     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.10.004     Document Type: Review

References (67)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 1 (2005) 10-30
2. Cummins E.R., Vick K., and Poole G.V. Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 70 5 (2004) 433-437
3. El-Serag H.B. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35 (2002) 72-78
4. Ibrahim S.M., Lewandowski R.J., Sato K.T., et al. Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol 14 11 (2008) 1664-1669
5. Garrean S., Hering J., Saied A., et al. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195 (2008) 508-520
6. Lim L., Gibbs P., Yip D., et al. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Intern Med J 35 4 (2005) 222-227
7. Liapi E., and Geschwind J.F. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 25 (2007) 978-986
8. Vogl T.J., Zangos S., Eichler K., et al. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 17 4 (2007) 1025-1034
9. Takayasu K., Arii S., Ikai I., et al., Liver cancer study group of Japan. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 2 (2006) 461-469
10. Cheng B.Q., Jia C.Q., Liu C.T., et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. J Am Med Assoc 299 14 (2008) 1669-1677
11. Pitt S.C., Knuth J., Keily J.M., et al. Hepatic neuroendocrine metastases: chemo- or bland embolization?. J Gastrointest Surg 12 (2008) 1951-1960
12. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rate and survival. Cancer 104 (2005) 1590-1602
13. Ruutiainen A.T., Soulen M., Tuite C.M., et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 16 (2005) 955-961 2007;18:847-55
14. Llovet J.M., Real M.I., Montaña X., et al., Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 349 9319 (2002) 1734-1739
15. Weber S.M., and Lee Jr. F.T. Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation. Oncology 19 11 Suppl 4 (2005) 27-32
16. Wallace J.R., Christians K.K., Quiroz F.A., et al. Ablation of liver metastasis: is preoperative imaging sufficiently accurate?. J Gastrointest Surg 5 (2001) 98-107
17. Cervone A., Sardi A., and Conaway G.L. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 66 (2000) 611-615
18. Abdalla E.K., Vauthey J., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-825
19. Curley S.A., Izzo F., Ellis L.M., et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232 (2000) 381-391
20. Weber SM, Lee FT Jr. In: Diagnostic Imaging. New York; CMP Media, LLC; 2005. p. 3-6.
21. Steed J., Saliken J., Donnelly B.J., et al. Correlation between thermosensor temperature and transrectal ultrasonography during prostate cryoablation. Can Assoc Radiol J 48 (1997) 186-190
22. Onik G., Gilbert J., Hoddick W., et al. Sonographic monitoring of hepatic cryosurgery in an experimental animal-model. AJR Am J Roentgenol 144 (1985) 1043-1047
23. Seifert J.K., and Morris D.L. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 228 (1998) 201-208
24. Seifert J.K., and Morris D.L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 23 (1999) 109-113
25. Adam R., Akpinar E., Johann M., et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 225 (1997) 39-50
26. Adam R., Hagopian E.J., Linhares M., et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 137 (2002) 1332-1339
27. Harada J., Dohi M., Mogami T., et al. Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system. Radiat Med 19 (2001) 291-296
28. Lee Jr. F., Chosy S.G., Littrup P.J., et al. CT-monitored percutaneous cryoablation in a pig liver model: pilot study. Radiology 211 (1999) 687-692
29. Seifert J.K., France M.P., Zhao J., et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 26 (2002) 1333-1341
30. Ng K.K., Lam C.M., Poon R.T., et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 11 (2004) 650-657
31. Pearson A.S., Izzo F., Fleming R.Y., et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178 (1999) 592-599
32. Liang P., and Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 72 1 (2007) 124-131
33. Seki T., Wakabayashi M., Nakagawa T., et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74 (1994) 817-825
34. Fahy B.N., and Jarnagin W. Evolving techniques in the treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin North Am 86 4 (2006) 1005-1022
35. Shibata T., Niinobu T., Ogata N., et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89 2 (2000) 276-284
36. Liang P., Dong B., Yu X., et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235 1 (2005) 299-307
37. Martin R.C., Scoggins C.R., and McMasters K.M. Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 86 6 (2007) 481-486
38. Shibata T., Iimuro Y., Yamamoto Y., et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223 2 (2002) 331-337
39. Sugiura N., Takara K., Ohto M., et al. Ultrasound-guided ethanol injection for the treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 21 (1983) 920-923
40. Ebara M., Okabe S., Kita K., et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43 3 (2005) 458-464
41. Lin X.-D., and La L.-W. Local injection therapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 5 (2006) 16-21
42. Guan Y.S., and Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 5 (2006) 495-500
43. Huang G.T., Lee P.H., Tsang Y.M., et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242 (2005) 36-42
44. Sung Y.M., Choi D., Lim H.K., et al. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 7 3 (2006) 187-192
45. Cho Y.B., Lee K.U., Suh K.S., et al. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. J Gastroenterol Hepatol 22 10 (2007) 1643-1649 2007;22(10):1643-9
46. Gournay J., Tchuenbou J., Richou C., et al. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis. Aliment Pharmacol Ther 16 8 (2002) 1529-1538
47. Daniele B., De Sio I., Izzo F., et al. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. J Clin Gastroenterol 36 1 (2003) 63-67
48. Lin S.M., Lin C.J., Lin C.C., et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54 (2005) 1151-1156
49. Lim L., Gibbs P., Yip D., et al. A prospective evaluation of treatment with selective internal radiation therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer 5 (2005) 1-6
50. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
51. Sharma R.A., Van Hazel G.A., Morgan B., et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25 (2007) 1099-1106
52. Siperstein A.E., Berber E., Ballem N., et al. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 246 (2007) 559-567
53. Sorensen S.M., Mortensen F.V., and Nielsen D.T. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48 3 (2007) 253-258
54. Park I.J., Kim H.C., Yu C.S., et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 15 1 (2007) 227-232
55. Berber E., Pelley R., and Siperstein A.E. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 23 (2005) 1358-1364
56. Solbiati L. Ablation for liver colorectal metastases: is it possible to equal the 5-year survival rates of surgery? Radiological Society of North America scientific assembly and annual meeting: Chicago (IL): November 28-December 3, 2004.
57. Yan D.B., Clingan P., and Morris D.L. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma - how many are too many?. Cancer 98 (2003) 320-330
58. Ruers T.J., Joosten J., Jager G.J., et al. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 88 (2001) 844-849
59. Weaver M.L., Atkinson D., and Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 76 (1995) 210-214
60. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
61. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103 (2005) 1201-1209
62. Lam C.M., Ng K.K., Poon R.T., et al. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 91 (2004) 334-338
63. Dettmer A., Kirchhoff T.D., Gebel M., et al. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma. World J Gastroenterol 12 23 (2006) 3707-3715
64. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 1 (2005) 122-130
65. Lencioni R.A., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228 1 (2003) 235-240
66. Koda M., Murawaki Y., Mitsuda A., et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 92 6 (2001) 1516-1524
67. Yamamoto J., Okada S., Shimada K., et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 34 (2001) 707-713